Applied DNA Sciences, Inc. (APDN) analyst actions
Rating and price-target actions on APDN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the APDN overview →
1 measured APDN analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA | Press release | +7.84% | +22.58% |
Keep exploring
More APDN: earnings → · SEC filings → · APDN overview →
Other Industrials names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Digital Ally, Inc. (DGLY) | 179 | 0.00% | 44% |
| AIRBORNE WIRELES NTWK (ABWN) | 176 | 0.00% | 39% |
| AIR CANADA INC VTG & VAR (ACDVF) | 175 | 0.00% | 46% |
| Iveda Solutions, Inc. (IVDA) | 175 | -0.01% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.